Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, Cytotoxicity and Molecular Docking Studies of Chalcone Incorporated 1,2,3-Triazol-1,3,5-Triazin-Quinazoline as Anti-Cancer Agents
Sujana Oggu, Bala Divya Mallavarapu, Pradeep Natarajan, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133412-133412
Closed Access | Times Cited: 20

Showing 20 citing articles:

The current landscape of 1,2,3‐triazole hybrids with anticancer therapeutic potential: Part I
Shanshan Huang, Zhi Xu, Yafei Zhuang
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access | Times Cited: 1
Design, Synthesis, and Biological Evaluation Studies of Novel Naphthalene-Chalcone Hybrids As Antimicrobial, Anticandidal, Anticancer, and VEGFR-2 Inhibitors
Derya Osmani̇ye, Begüm Nurpelin Sağlık, Narmin Khalilova, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6669-6678
Open Access | Times Cited: 14
Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation
Fathy M. Abdelrazek, Magdi E. A. Zaki, Sami A. Al‐Hussain, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29221-e29221
Open Access | Times Cited: 5
Quinazoline derivatives and hybrids: recent structures with potent bioactivity
Ibrahim A. Bala, Abdullah M. Asiri, Reda M. El‐Shishtawy
Medicinal Chemistry Research (2024)
Closed Access | Times Cited: 5
Synthesis and Screening of Novel 2,4-Bis Substituted quinazolines as Tubulin Polymerization Promotors and Antiproliferative Agents
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry (2025) Vol. 16, Iss. 3, pp. 1410-1424
Closed Access
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
Design, Synthesis and Evaluation of Quinazoline-Chalcone Hybrids as Inducers of Cell-Cycle Arrest and Apoptosis in Breast Cancer via DNA Damage and CDK2/ATR Inhibition
Giulia Rodrigues Stringhetta, Eduardo Bustos Mass, Izabela Natália Faria Gomes, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100250-100250
Open Access
The antibreast cancer therapeutic potential of quinazoline hybrids–Part I
Wei Chen, Ruo Wang, Yidan Lin, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
An Updated Overview on the Synthesis and Anticancer Evaluation of Quinazoline Derivatives
Jasneet Kaur, Sukhmeet Kaur, Amit Ȧnand, et al.
ChemistrySelect (2023) Vol. 8, Iss. 30
Open Access | Times Cited: 10
Comprehensive study of the molecular structure and nonlinear optical response of two novel halogenated pyrenyl-chalcones
Saleh K. Alsaee, Ibrahim Abdul Razak, Suhana Arshad, et al.
Journal of Molecular Structure (2023) Vol. 1279, pp. 135021-135021
Closed Access | Times Cited: 9
Synthesis, characterization, cytotoxic evaluation, and molecular docking studies of novel 1,2,3-triazole-based chalcones for potential anticancer applications
Venkateswarlu Banoji, A. Kishore Kumar, V. Sunitha, et al.
Results in Chemistry (2023) Vol. 7, pp. 101294-101294
Open Access | Times Cited: 9
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Advances in chalcone derivatives: Unravelling their anticancer potential through structure-activity studies
Khursheed Ahmad Sheikh, Amisha Gupta, Mohammad Faisal Umar, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137154-137154
Closed Access | Times Cited: 7
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 7
The current landscape of 1,2,3‐triazole‐(fused) six‐membered nitrogen‐containing heteroaromatic ring hybrids with anticancer therapeutic potential
Zhi Xu, Rongqiang Li, Zhiwei Huang, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access | Times Cited: 2
An experimental and computational analysis on 2,6-diamine-7H-purine ligand with spectroscopic, AIM, NLO and biological activity
Kamalanathan Guna, P. Sakthivel, I. Ragavan, et al.
Optics & Laser Technology (2023) Vol. 168, pp. 109872-109872
Closed Access | Times Cited: 4
Advances in chalcone-based anticancer therapy: mechanisms, preclinical advances, and future perspectives
Shefali Chowdhary, Preeti Preeti, Shekhar Shekhar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access | Times Cited: 1
Synthesis of 3,4-dihydro-1,3,5-triazin-2(1H)-one derivatives by recycling 2H-1,3,5-oxadiazine-2,4(3H)-diimines: their spectral characteristics and molecular structure
Ihor O. Pokotylo, Pavlo V. Zadorozhnii, Vadym V. Kiselev, et al.
Structural Chemistry (2023) Vol. 34, Iss. 6, pp. 2273-2279
Closed Access | Times Cited: 3
New 6-nitro-4-substituted quinazoline derivatives targeting epidermal growth factor receptor: design, synthesis and in vitro anticancer studies
Ayman Farag, Aya H Othman, Mohamed K. El‐Ashrey, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 19, pp. 2025-2041
Closed Access
Page 1

Scroll to top